Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Ginger beer contains more sugar than Coke, patient saves choking girl in surgery and new cancer pill breakthrough

A round-up of the morning’s health news headlines on Thursday 12 June.

Fizzy drinks such as ginger beer and cloudy lemonade contain more sugar than Coca-Cola and Pepsi, a study reported in the Guardian shows.

About 80% of 330ml cans of fizzy drinks contain more than six teaspoons of sugar, according to the campaign Action on Sugar, which has analysed 232 drinks from supermarkets.

The worst offenders are ginger beers, such as Old Jamaica ginger beer and Jammin sparkling ginger beer flavour drink, which have the equivalent of 13 teaspoons of sugar per 330ml serving. Waitrose, Marks & Spencer and Sainsbury’s ginger beers have 11. Coca-Cola and Pepsi have nine.

Also very high in sugar are Club Orange (12 teaspoons), Sainsbury’s cloudy lemonade (11 teaspoons) and Fanta grape-flavoured drink (11 teaspoons).

Patient in the waiting room of a GP surgery in Salford rescued an eight year-old girl from choking on a sweet, the Daily Mirror reports.

One patient gave the Olivia Oxton the Heimlich manoeuvre, while another banged her on the back.

Olivia’s mother, Louise, is trying to trace the helpers to thank them. Olivia’s aunt, Julie, said: ‘At first I thought Olivia just had a tickly cough. But I noticed that her lips were blue and her eyes were bloodshot.’

The Telegraph reports on a pill which boosts the body’s natural defences could help fight off all cancers and prevent them returning.

Scientists say that delta-inhibitors – previously used for leukaemia patients – work for other cancers too.

The drugs, which are taken orally as pills, were so successful in trials with patients with leukaemia that the control group on placebos was switched to the delta-inhibitor medication.

Have your say